Summary

Eligibility
for people ages 18-100 (full criteria)
Location
at San Francisco 5391959, California 5332921
Dates
study started
study ends around

Description

Summary

Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing self-guided vs. supported dCBT (SilverCloud).

Official Title

SUPERA: Supporting Peer Interactions to Expand Access to Digital Cognitive Behavioral Therapy for Spanish-speaking in the San Francisco Mission Community

Keywords

Depression, Anxiety, Depression, Anxiety Disorders, Behavioral: Supported dCBT, Behavioral: Unsupported dCBT, Peer-Support

Eligibility

You can join if…

Open to people ages 18-100

  1. PHQ-9 ≥ 10 or GAD-7 ≥ 8
  2. Has access to the Internet via smartphone and/or broadband at home, and basic level of technological literacy or willingness to undergo a brief technology use training
  3. ≥18 years of age
  4. Preference for receiving medical care in Spanish
  5. Not in concurrent psychotherapy
  6. If currently taking an antidepressant medication, patient must have been on a stable dose for at least 6 weeks, and have no plans to change the dose. We will permit patients on antidepressants to enter the study, as this will increase generalizability. Antidepressant status will be monitored at each assessment to control for those effects, if necessary.

You CAN'T join if...

  1. Currently receiving psychotherapy, as this treatment will be offered as a frontline treatment for depression and anxiety, however, patients are allowed to be referred to treatment while participating in this study and initiation of treatment will be monitored and considered in analyses
  2. Visual, hearing, voice, or motor impairment or illiteracy that would prevent completion of study procedures
  3. Diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder
  4. Severe suicidality (as assessed by expressing suicidal ideation, plan, and intent). Although procedures with back-up plans are in place for patients who develop suicidality (see Human Subjects Section), patients assessed with severe suicidality will be referred to more-intensive treatment resources.

Location

  • Zuckerberg San Francisco General accepting new patients
    San Francisco 5391959 California 5332921 94110 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Berkeley
ID
NCT07186816
Study Type
Interventional
Participants
Expecting 213 study participants
Last Updated